D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 92 Citations 29,705 344 World Ranking 5477 National Ranking 161

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Cancer
  • Surgery

Pieter E. Postmus mainly investigates Internal medicine, Lung cancer, Surgery, Cardiology and Pulmonary hypertension. His Internal medicine research incorporates elements of Gastroenterology and Oncology. His Oncology research is multidisciplinary, relying on both Carcinoma, Metastasis and Cohort.

His Lung cancer study combines topics in areas such as Clinical trial, Chemotherapy, Nuclear medicine, Thoracotomy and Stage. Pieter E. Postmus has researched Surgery in several fields, including Respiratory disease and Prophylactic cranial irradiation. The Cardiology study combines topics in areas such as Anesthesia, Magnetic resonance imaging and Blood pressure.

His most cited work include:

  • The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. (2940 citations)
  • Prophylactic Cranial Irradiation in Extensive Small-Cell Lung Cancer (726 citations)
  • Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial. (684 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of investigation include Internal medicine, Lung cancer, Surgery, Oncology and Respiratory disease. Pieter E. Postmus has included themes like Gastroenterology and Cardiology in his Internal medicine study. His Cardiology study combines topics from a wide range of disciplines, such as COPD and Blood pressure, Diastole.

Pieter E. Postmus combines subjects such as Stage, Cancer, Carcinoma and Radiology with his study of Lung cancer. His Oncology study integrates concerns from other disciplines, such as Etoposide, Toxicity and Docetaxel. His study in Pathology is interdisciplinary in nature, drawing from both Cancer research and Birt–Hogg–Dubé syndrome.

He most often published in these fields:

  • Internal medicine (45.06%)
  • Lung cancer (37.11%)
  • Surgery (26.51%)

What were the highlights of his more recent work (between 2012-2021)?

  • Internal medicine (45.06%)
  • Lung cancer (37.11%)
  • Oncology (24.82%)

In recent papers he was focusing on the following fields of study:

Internal medicine, Lung cancer, Oncology, Birt–Hogg–Dubé syndrome and Pneumothorax are his primary areas of study. Internal medicine is frequently linked to Gastroenterology in his study. The various areas that Pieter E. Postmus examines in his Lung cancer study include Stage, Cancer, Primary tumor and Lung.

The concepts of his Oncology study are interwoven with issues in Nab-paclitaxel and Durvalumab. Pneumothorax is a subfield of Surgery that Pieter E. Postmus tackles. His Surgery research focuses on Incidence and how it connects with Cohort.

Between 2012 and 2021, his most popular works were:

  • Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution (420 citations)
  • Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors. (183 citations)
  • Phase III Trial of Ipilimumab Combined With Paclitaxel and Carboplatin in Advanced Squamous Non–Small-Cell Lung Cancer (156 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Surgery

His primary scientific interests are in Internal medicine, Lung cancer, Oncology, Surgery and Pneumothorax. His work on Chemotherapy, Autopsy and Myocardial infarction as part of general Internal medicine research is frequently linked to Power output, thereby connecting diverse disciplines of science. His Lung cancer research integrates issues from Stage, Cancer, Sputum and Radiology.

His Oncology research is multidisciplinary, incorporating elements of Nivolumab, Disease and Targeted therapy. His study focuses on the intersection of Surgery and fields such as Incidence with connections in the field of Cohort. His biological study spans a wide range of topics, including Emergency medicine and Medical emergency.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours.

Peter Goldstraw;John Crowley;Kari Chansky;Dorothy J. Giroux.
Journal of Thoracic Oncology (2007)

3358 Citations

Prophylactic Cranial Irradiation in Extensive Small-Cell Lung Cancer

Berend J Slotman;Corinne Faivre-Finn;Gijs Kramer;Elaine M Rankin.
The New England Journal of Medicine (2007)

1061 Citations

Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial.

Harm van Tinteren;Otto S Hoekstra;Egbert F Smit;Jan Ham van den Bergh.
The Lancet (2002)

946 Citations

Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension.

Serge A van Wolferen;Johannes T Marcus;Anco Boonstra;Koen M J Marques.
European Heart Journal (2007)

767 Citations

The international association for the study of lung cancer lung cancer staging project: Proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer

Frances A. Shepherd;John J. Crowley;Paul Van Houtte;Pieter E. Postmus.
Journal of Thoracic Oncology (2007)

611 Citations

Topotecan, a new active drug in the second-line treatment of small-cell lung cancer: a phase II study in patients with refractory and sensitive disease. The European Organization for Research and Treatment of Cancer Early Clinical Studies Group and New Drug Development Office, and the Lung Cancer Cooperative Group.

Andrea Ardizzoni;Heine Hansen;Per Dombernowsky;Teresa Gamucci.
Journal of Clinical Oncology (1997)

602 Citations

Prognostic factors in patients with pleural mesothelioma : The European Organization for Research and Treatment of Cancer Experience

D Curran;T Sahmoud;P Therasse;J van Meerbeeck.
Journal of Clinical Oncology (1998)

543 Citations

The IASLC Lung Cancer Staging Project: proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancer.

Eric Vallières;Frances A. Shepherd;John J. Crowley;Paul Van Houtte.
Journal of Thoracic Oncology (2009)

530 Citations

Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution

Nicholas McGranahan;Rachel Rosenthal;Crispin T. Hiley;Crispin T. Hiley;Andrew J. Rowan.
Cell (2017)

490 Citations

Deletion of a DNA sequence at the chromosomal region 3p21 in all major types of lung cancer

Klaas Kok;Jan Osinga;Ben Carritt;Mary B. Davis.
Nature (1987)

475 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Pieter E. Postmus

Egbert F. Smit

Egbert F. Smit

VU University Medical Center

Publications: 89

Jos H. Beijnen

Jos H. Beijnen

Antoni van Leeuwenhoek Hospital

Publications: 83

Jan H.M. Schellens

Jan H.M. Schellens

Utrecht University

Publications: 75

Suresh Senan

Suresh Senan

University of Amsterdam

Publications: 72

Dirk De Ruysscher

Dirk De Ruysscher

Maastricht University

Publications: 69

Johan Vansteenkiste

Johan Vansteenkiste

KU Leuven

Publications: 68

Marc Humbert

Marc Humbert

University of Paris-Saclay

Publications: 66

Valerie W. Rusch

Valerie W. Rusch

Memorial Sloan Kettering Cancer Center

Publications: 64

Adriaan A. Lammertsma

Adriaan A. Lammertsma

Vrije Universiteit Amsterdam

Publications: 63

Robert Naeije

Robert Naeije

Vrije Universiteit Brussel

Publications: 59

Benjamin Besse

Benjamin Besse

Institut Gustave Roussy

Publications: 54

Frank C. Detterbeck

Frank C. Detterbeck

Yale University

Publications: 53

William D. Travis

William D. Travis

Memorial Sloan Kettering Cancer Center

Publications: 51

Ronald Boellaard

Ronald Boellaard

Vrije Universiteit Amsterdam

Publications: 49

Frances A. Shepherd

Frances A. Shepherd

Princess Margaret Cancer Centre

Publications: 48

Ben J. Slotman

Ben J. Slotman

University of Amsterdam

Publications: 47

Trending Scientists

Jarek Rossignac

Jarek Rossignac

Georgia Institute of Technology

Joseph L. Gastwirth

Joseph L. Gastwirth

George Washington University

Jing Chen

Jing Chen

Southeast University

Henrik Stang

Henrik Stang

Technical University of Denmark

Akira Sekiguchi

Akira Sekiguchi

University of Tsukuba

Sébastien Perrier

Sébastien Perrier

University of Warwick

Philip D. Rack

Philip D. Rack

University of Tennessee at Knoxville

Elizabeth M. Simpson

Elizabeth M. Simpson

University of British Columbia

Jon D. Witman

Jon D. Witman

Brown University

James K. M. Brown

James K. M. Brown

Norwich Research Park

Keith T. Jones

Keith T. Jones

University of Southampton

Mark J. Walker

Mark J. Walker

University of Queensland

Ashesh D. Mehta

Ashesh D. Mehta

Feinstein Institute for Medical Research

Florian Engert

Florian Engert

Harvard University

Joseph M. Zmuda

Joseph M. Zmuda

University of Pittsburgh

David Johnston

David Johnston

Fermilab

Something went wrong. Please try again later.